Researchers at the Josep Carreras Leukaemia Research Institute (IJC) discover that a single molecular switch, HDAC7, controls ...
A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) ...
New approval allows teplizumab use in children as young as 1 year, significantly delaying stage 3 type 1 diabetes onset and ...
TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...
Leucine-rich repeat-containing 8A (LRRC8A) is a ubiquitously expressed transmembrane protein that functions as the essential ...
Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover ...
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has presented new phase I clinical data for its cancer therapy candidate HMBD ...
The Phase 2 study (NCT06954467) aiming to evaluate the safety and efficacy of JS207 in combination with JS007 included a safety run-in period and a randomized expansion phase, which enrolled patients ...
Lilit Karapetyan, MD, MS, discusses a single-center trial of reduced-intensity conditioning before tumor-infiltrating lymphocyte therapy in melanoma. Lilit Karapetyan, MD, MS of the Moffitt Cancer ...
Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable ...
Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...
MSCs improve therapeutic consistency and precision across cell therapies. The approach also supports scalable allogeneic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results